USP's Part D Formulary Guidelines Add 38 Unique Drug Categories/Classes
Executive Summary
In an effort to make a more usable two-tiered model guideline for Medicare Part D formularies, USP proposed 38 more unique categories and classes in its version 5 model guidelines compared to version 4.
You may also be interested in...
How Often Should Part D's Model Formulary Be Revised? USP And CMS Disagree
In releasing its first revisions to the model guidelines for Medicare Part D formularies since 2008, the U.S. Pharmacopeia advocates that returning to an annual review cycle would better serve patients.
How Often Should Part D's Model Formulary Be Revised? USP And CMS Disagree
In releasing its first revisions to the model guidelines for Medicare Part D formularies since 2008, the U.S. Pharmacopeia advocates that returning to an annual review cycle would better serve patients.
USP Offers Few Changes In Part D Draft Model Formulary Guidelines For 2009
The U.S. Pharmacopeia's draft model formulary guidelines version 4.0 do not include additional therapeutic categories or pharmacologic classes compared with the current version